Advertisement
Person › Details
Craig A. Tooman (Aratana Therapeutics Inc. (Nasdaq: PETX))
Tooman, Craig A. (Silence Therapeutics 202202– CEO joined 1/21 before Vyome Tx + Aratana Tx + Avanzar Medical + Enzon)
Organisation | Aratana Therapeutics Inc. (Nasdaq: PETX) | |
Today | Aratana (Group) | |
Group | Aratana (Group) | |
Former/major organisation | Enzon Pharmaceuticals Inc. (Nasdaq: ENZN) | |
Group | Enzon (Group) | |
Product | animal health | |
Product 2 | pharmaceutical | |
CureVac N.V.. (12/23/20). Web Site: Leadership – Executive Board, Supervisory Board and Scientific Advisory Board. [https://www.curevac.com, 12/23/20]
Record changed: 2024-02-10 |
Advertisement
More documents for Craig A. Tooman
- [1] Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London....
- [2] Silence Therapeutics plc. (2/21/22). "Press Release: Silence Therapeutics Appoints Craig Tooman President and Chief Executive Officer. Mark Rothera Steps Down as President and CEO". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top